Sign up to save your podcasts
Or
Share Impact of high-dose Vitamin D on MS relapse, the role of AI in neurology education, and a 4D animal model that shows precursors of MS lesions before they appear.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Impact of high-dose Vitamin D on MS relapse, the role of AI in neurology education, and a 4D animal model that shows precursors of MS lesions before they appear.
In this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vitamin D reduced MRI evidence of disease activity in patients with clinically isolated syndrome or early relapsing MS; an animal brain map, revealing changes in inflammation, immune activity, and cell repair that preceded the appearance of MS lesions; and a discussion of the challenges and opportunities of using AI in neurology education.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
In this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vitamin D reduced MRI evidence of disease activity in patients with clinically isolated syndrome or early relapsing MS; an animal brain map, revealing changes in inflammation, immune activity, and cell repair that preceded the appearance of MS lesions; and a discussion of the challenges and opportunities of using AI in neurology education.
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
138 Listeners
NEJM This Week
323 Listeners
JAMA Clinical Reviews
498 Listeners
Neurology® Podcast
297 Listeners
Practical Neurology Podcast
46 Listeners
JAMA Neurology Author Interviews
13 Listeners
Annals On Call Podcast
191 Listeners
JAMA Medical News
95 Listeners
The Clinical Problem Solvers
515 Listeners
Neurology Minute
137 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Neurology Exam Prep Podcast
190 Listeners
The Curious Clinicians
375 Listeners
The Lancet Neurology in conversation with
6 Listeners
Continuum Audio
83 Listeners